The DAP facility consisted of a 480 square feet, two room suite with an office space and a separate, unclassified production ...

Drugmaker Alembic Pharma Ltd. announced on Wednesday, June 18, that the United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the company's API-III ...

Vadodara: Alembic Pharmaceuticals Limited has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its API-III Facility at Karakhadi. The inspection was ...

Hikal said that it has successfully cleared the Good Manufacturing Practices (GMP) inspection conducted by the Brazilian Health Regulatory Agency (ANVISA) at its API manufacturing unit in Jigani, ...

Hikal Ltd. has announced the successful completion of the Good Manufacturing Practices (GMP) audit conducted by the Brazilian Health Regulatory Agency (ANVISA) at its manufacturing facility located in ...

Natco Pharma Ltd. reported on Friday that its active pharmaceutical ingredient manufacturing facility in Mekaguda, Hyderabad, received one observation from the US Food And Drugs Administration which ...

NATCO Pharma announced conclusion of US FDA Inspection at its Mekaguda, Hyderabad Active Pharmaceutical Ingredients (API) Unit The U.S. Food and Drug Administration (FDA) had conducted an inspection ...

The approval is for its upcoming manufacturing facility dedicated to Bulk Drugs, Drug Intermediates, and Specialty Chemicals, including Active Pharmaceutical Ingredients (APIs).